Coronavirus infection could lead to long-term cognitive decline and Alzheimer's

Scientists are concerned the coronavirus could cause long-term damage to the brain and central nervous system, potentially leading to Alzheimer’s in later life. 

US and UK-based academics are planning a large-scale global study to investigate the possibility SARS-CoV-2, the virus which causes Covid-19, could lead to cognitive decline, Alzheimer’s, Parkinson’s and other forms of dementia years after infection. 

The full repercussions of brain-related problems caused by the coronavirus will not be fully understood for decades as survivors age but autopsies, mouse studies and data from other respiratory viruses are cause for concern, researchers warn. 

There is currently no evidence the coronavirus does cause Alzheimer’s but it has been found the virus is able to invade the brain and scientists hope their global study can shed light on the issue.   

‘Since the flu pandemic of 1917 and 1918, many of the flu-like diseases have been associated with brain disorders,’ said lead author Dr Gabriel de Erausquin at the University of Texas. 

‘Those respiratory viruses included H1N1 and SARS-CoV. The SARS-CoV-2 virus, which causes COVID-19, is also known to impact the brain and nervous system.’ 

The research will be carried out in conjunction with British-based experts at the University of Leicester and the Queen’s Medical Centre in Nottingham.  

The Spanish flu of 1918 was tied by scientists to a spike in brain afflictions such as sleep disruption, anxiety and psychosis, symptoms also seen in Covid patients. 

However, there is currently not enough data on how viruses impact on long-term cognitive health. 

The SARS-CoV-2 pandemic, the researchers write, offers ‘a unique — if unwelcome — opportunity’ to learn more about how viruses damage the brain.  

Previous research has proved the coronavirus can cause delirium, strokes and even paralysis due to its impact on the central nervous sy
stem.

However, Dr de Erausquin says the impact will not be limited to these short-term acute symptoms seen in hospitals and will likely manifest into chronic conditions.  

Studies have found that SARS-CoV-2 has been found in brain tissue and experts believe it can attack nerves in the organ. 

The virus is also known to affect the sense of smell in many patients and it is thought it does this because the olfactory bulb in the brain which controls smell is rife with ACE2, the receptor which the virus latches onto in order to infect human cells. 

‘The basic idea of our study is that some of the respiratory viruses have affinity for nervous system cells,’ said senior author Dr Sudha Seshadri, at the University of Texas. 

‘Olfactory cells are very susceptible to viral invasion and are particularly targeted by SARS-CoV-2, and that’s why one of the prominent symptoms of COVID-19 is loss of smell.’ 

Dr Erausquin adds that the virus invades the hippocampus via the olfactory bulb and this part of the brain is integral to memory and learning. 

He says this pathway is thought to be ‘one of the sources’ of the cognitive decline seen in some Covid patients. 

‘We suspect it may also be part of the reason why there will be an accelerated cognitive decline over time in susceptible individuals,’ he adds. 

Writing in the journal Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the researchers outline their study plan. 

Scientists in more than 30 countries will follow the lives of around 40,000 participants. 

It will compare people who had the virus with those who did not catch Covid-19 and is being initially funded by the US-based Alzheimer’s Association. 

The first batch of results are not expected until 2022.